Genscript Biotech Corporation
GNNSF | OTC
$4.50
+$0.12 (+2.74%)
Nov 2, 2026, 10:42 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -129.13M | -445.07M | -25.46M | n/a | -175.12M | -1.9M | -93.58M | -91.34M | -135.51M | -267.59M | -91.12M |
Depreciation & Amortization | 40.35M | 39.15M | 34.89M | n/a | 40.3M | 38.52M | 35.52M | 31.16M | 30.02M | 22.86M | 23.01M |
Stock-Based Compensation | n/a | 5.22M | 9.58M | n/a | 53.35M | 21.73M | 38.86M | 28.7M | 36.45M | 25.18M | 14.51M |
Other Working Capital | -12.61M | 27.99M | 69.72M | n/a | 14.81M | -3.45M | -26.29M | 102.13M | 11.46M | 128.64M | 15.97M |
Other Non-Cash Items | 181.8M | 495.43M | 213.61M | n/a | 68.15M | -63.6M | -111.82M | -123.21M | -28.7M | 47.94M | -42.62M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -9M | -17.58M | -60.73M | 32.78M | -58.91M |
Change in Working Capital | -36.34M | -1.82M | 69.87M | n/a | 93.18M | -94.5M | -56.15M | 96.39M | 35.74M | 70.67M | 60.37M |
Operating Cash Flow | 56.68M | 92.9M | 232.62M | n/a | 79.86M | -99.74M | -187.17M | -58.3M | -62M | -100.94M | -35.85M |
Capital Expenditures | -47.58M | -51.71M | -32.13M | n/a | -134.03M | -172.25M | -80.2M | -142.19M | -73.93M | -64.29M | -68.76M |
Cash Acquisitions | 142.77K | -8.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -809.99M | -1.16B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 851.23M | 1.1B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 7.1M | 48.78M | -66.52M | n/a | -999.03M | 269.06M | -374.35M | 35.76M | -262.95M | 20.66M | -100.16M |
Investing Cash Flow | 145.76K | -73.31M | -98.65M | n/a | -1.13B | 96.82M | -454.54M | -106.42M | -336.87M | -43.63M | -168.92M |
Debt Repayment | -7.78M | 85.73M | n/a | n/a | -22.27M | n/a | -2.4M | n/a | 3.46M | n/a | -27.81M |
Common Stock Repurchased | n/a | -225.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.83M | 187.24M | 26.4M | n/a | 27.83M | 48.24M | 1.02B | 411.09M | 4.77M | 369.16M | 560.8M |
Financial Cash Flow | -12.2M | -171.29M | 26.4M | n/a | 5.57M | 48.24M | 1.02B | 411.09M | 8.23M | 369.16M | 532.99M |
Net Cash Flow | 45.1M | -150.72M | 293.21M | -399.3M | 399.3M | 49.07M | 373.34M | 241.75M | -398.73M | 223.36M | 328.56M |
Free Cash Flow | 9.1M | 41.19M | 200.49M | n/a | -54.17M | -271.99M | -267.37M | -200.48M | -135.92M | -165.22M | -104.61M |
Adj. Free Cash Flow | 9.1M | 35.97M | 190.92M | n/a | -107.52M | -293.72M | -306.22M | -229.19M | -172.37M | -190.4M | -119.12M |
Maintenance CapEx | -40.35M | n/a | n/a | n/a | -134.03M | -39.08M | n/a | -92.45M | -2.32M | -34.18M | -16.03M |
Growth CapEx | -7.22M | -51.71M | -32.13M | n/a | n/a | -133.16M | -80.2M | -49.73M | -71.6M | -30.11M | -52.73M |
Owner Earnings | 16.33M | 92.9M | 232.62M | n/a | -54.17M | -138.83M | -187.17M | -150.75M | -64.32M | -135.11M | -51.88M |
Add to Watchlist
Select watchlists to add or remove GNNSF